Recombinant Subunit Herpes Zoster Vaccine in VZV-Seronegative Organ Transplant Recipients
Clinical trial NCT03685682 · COMPLETED
Trial details
- NCT number
- NCT03685682
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-25
- Primary completion
- 2019-09-05
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.